Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

Xintela's interim analysis of data from the knee osteoarthritis clinical study shows safety and positive efficacy results, 18 months after treatment with XSTEM. The results demonstrate statistically s ...

On March 12, 2025, China's Center for Drug Evaluation (CDE) approved Tasly's Investigational New Drug (IND) application for NR-20201, an allogeneic adipose-derived mesenchymal stromal cell, sparking ...

BMP9, a less-studied member of the BMP family, exhibits strong osteogenic effects on mesenchymal stem cells (MSCs ... been shown to activate osteogenic markers such as Runx2 and ALP in MSCs ...

Adipose tissue-derived mesenchymal Stem Cells (ADSCs) can be used to stimulate neovascularization ... injection of α-MEM containing ADSCs labeled with a fluorescent marker were performed in Groups ...

The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, ...

Ovarian cancer is the deadliest form of gynecologic cancer, taking the lives of more than 13,000 women in the U.S. each year. The most common type, high-grade serous ovarian carcinoma (HGSOC), is ...

Background: Human umbilical cord mesenchymal stem cells (UCMSCs) are being investigated in various ... Changes in various biochemical markers supported the efficacy observed in FBG and OGTT levels.

9–11 The ability of mesenchymal stem cells (MSCs) to differentiate into both osteoblasts ... analysis assessed for the presence of MSC surface markers CD90, CD73 and CD105 and absence of ...